|
MTO1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.7065463465733E-14 |
| Normal-vs-Stage2 |
4.11210000050843E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.712200E-01 |
| Stage1-vs-Stage3 |
3.203800E-04 |
| Stage1-vs-Stage4 |
1.752360E-04 |
| Stage2-vs-Stage3 |
1.126590E-01 |
| Stage2-vs-Stage4 |
5.902100E-02 |
| Stage3-vs-Stage4 |
6.133800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
7.98000554524947E-11 |
| Normal-vs-Asian |
1.496030E-02 |
| Caucasian-vs-AfricanAmerican |
8.797400E-01 |
| Caucasian-vs-Asian |
4.195600E-01 |
| AfricanAmerican-vs-Asian |
3.907600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.63447033685316E-12 |
| Male-vs-Female |
1.173610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1300999852869E-09 |
| Normal-vs-Age(41-60Yrs) |
1.63702384980979E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.18510000005168E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.274430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.112800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.830200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.625800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.755200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.565600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.584440E-01 |
| Normal-vs-Grade 2 |
3.774103252141E-11 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
5.492200E-02 |
| Grade 1-vs-Grade 3 |
5.371800E-04 |
| Grade 1-vs-Grade 4 |
1.09709999995822E-06 |
| Grade 2-vs-Grade 3 |
4.045000E-04 |
| Grade 2-vs-Grade 4 |
8.15800005327105E-09 |
| Grade 3-vs-Grade 4 |
3.965200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.08019999944808E-07 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.63102864547682E-12 |
| Normal-vs-N1 |
1.16389999860189E-08 |
| N0-vs-N1 |
5.925900E-02 |
|
|
